Comparative Pharmacology
Head-to-head clinical analysis: ENULOSE versus HALFLYTELY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ENULOSE versus HALFLYTELY.
ENULOSE vs HALFLYTELY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed from the gastrointestinal tract. It is metabolized by colonic bacteria to form low molecular weight organic acids, which lower the colonic pH and increase osmotic pressure, resulting in increased stool volume and laxative effect. In hepatic encephalopathy, the acidification of the colon inhibits the growth of ammonia-producing bacteria and promotes the conversion of ammonia to ammonium ion, which is trapped in the colon and excreted, thereby reducing systemic ammonia levels.
PEG 3350 is an osmotic agent that causes water retention in the colon, leading to bowel evacuation. Electrolytes (sodium sulfate, potassium chloride, magnesium sulfate, sodium bicarbonate) prevent significant electrolyte shifts.
15-45 mL orally once daily, titrated to produce 2-3 soft stools per day. Maximum 60 mL per day.
Oral: 1 liter (provided as powder for reconstitution) administered at a rate of 240 mL every 10 minutes until rectal effluent is clear or 4 liters total is consumed. Typically given as split-dose: half the volume the evening before and half the morning of colonoscopy.
None Documented
None Documented
Terminal elimination half-life is 2.1 hours in normal renal function; prolonged to up to 6 hours in renal impairment.
Not applicable; PEG 3350 is not significantly absorbed and does not have a systemic half-life. The colon transit time is approximately 1 hour after ingestion.
Primarily renal (95% unchanged by glomerular filtration); biliary/fecal less than 5%.
Primarily fecal elimination of unabsorbed PEG 3350; negligible systemic absorption <0.06%. Electrolytes are excreted renally and fecally.
Category C
Category C
Laxative
Laxative